pharma · Acute Myeloid Leukemia · Breast Cancer
First People's Hospital
The First People's Hospital of Lianyungang
First People's Hospital clinical programs — 186 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, CN
- Programs
- 1136
- Drugs
- 626
- Patents
- 123
First People's Hospital projects
186 ClinicalTrials.gov programs sponsored by First People's Hospital.
First People's Hospital has 186 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Optimal hypoglycemic treatment
The First People's Hospital of Lianyungang
Type2 Diabetes
1 trial -
Ornithine aspartate granule
The First People's Hospital of Lianyungang
Non-alcoholic Fatty Liver Disease
1 trial -
PCIA group
The First People's Hospital of Lianyungang
Postoperative Pain
1 trial -
PEG-somatropin
The First People's Hospital of Lianyungang
Growth Hormone Deficiency
1 trial -
Parecoxib
The First People's Hospital of Lianyungang
Emergence Delirium
1 trial -
Parecoxib
The First People's Hospital of Lianyungang
Postoperative Pain Management, Pain Threshold, Shoulder Pain, Laparoscopies
1 trial -
Pegylated liposomal doxorubicin
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Pharmacotherapy
The First People's Hospital of Lianyungang
Diabetes Mellitus, Type 2
1 trial -
Pramipexole
The First People's Hospital of Lianyungang
Restless Legs Syndrome
1 trial -
Prothrombin Complex Concentrate, Human
The First People's Hospital of Lianyungang
Cardiac Surgical Procedures
1 trial -
Raltitrexed
The First People's Hospital of Lianyungang
Head and Neck Squamous Cell Carcinoma
1 trial -
Realgar-Indigo Naturalis Formulation Combined with Anlotinib
The First People's Hospital of Lianyungang
Platinum-resistant Ovarian Cancer (PROC)
1 trial -
Recaticimab
The First People's Hospital of Lianyungang
STEMI - ST Elevation Myocardial Infarction
1 trial -
Recaticimab and Statin
The First People's Hospital of Lianyungang
Intracranial Atherosclerosis
1 trial -
Recombinant Human Adenovirus Type 5 injection
The First People's Hospital of Lianyungang
Hepatocellular Carcinoma
1 trial -
Recombinant Staphylokinase
The First People's Hospital of Lianyungang
ST-segment Elevation Myocardial Infarction (STEMI)
1 trial -
Recombinant Staphylokinase
The First People's Hospital of Lianyungang
Acute Myocardial Infarction
1 trial -
Recombinant staphylokinase
The First People's Hospital of Lianyungang
ST Elevation Myocardial Infarction
1 trial -
Remimazolam Besylate for Injection
The First People's Hospital of Lianyungang
Thoracic Surgery
1 trial -
Resveratrol
The First People's Hospital of Lianyungang
Pancreatitis, Acute
1 trial -
Rifaximin
The First People's Hospital of Lianyungang
IBS - Irritable Bowel Syndrome
1 trial -
Rituximab
The First People's Hospital of Lianyungang
Hemophagocytic Lymphohistiocytosis
1 trial -
Ropivacaine
The First People's Hospital of Lianyungang
End Stage Renal Disease (ESRD)
1 trial -
Ropivacaine
The First People's Hospital of Lianyungang
Radius Fractures
1 trial -
Rosuvastatin
The First People's Hospital of Lianyungang
Hyperlipidemia
1 trial -
Rucacuzumab plus standard therapy
The First People's Hospital of Lianyungang
Acute Ischemic Stroke AIS
1 trial -
Ruxolitinib
The First People's Hospital of Lianyungang
Safety and Efficacy
2 trials -
S-1
The First People's Hospital of Lianyungang
Pancreatic Cancer
1 trial -
S-ketamine & Ropivacaine
The First People's Hospital of Lianyungang
Postoperative Analgesia
1 trial -
SGLT2 inhibitor
The First People's Hospital of Lianyungang
Type2 Diabetes
1 trial -
SZ5202
The First People's Hospital of Lianyungang
Multiple Myeloma
1 trial -
Sertraline
The First People's Hospital of Lianyungang
Efficacy, Team
1 trial -
Sertraline Hydrochloride
The First People's Hospital of Lianyungang
COVID-19 Vaccine Adverse Reaction
1 trial -
Shenfu Injection
The First People's Hospital of Lianyungang
Septic Shock
2 trials -
Skin stretching device (SSD)
The First People's Hospital of Lianyungang
Trauma
1 trial -
Standard BP control
The First People's Hospital of Lianyungang
Hypertension
1 trial -
Statin
The First People's Hospital of Lianyungang
Acute Coronary Syndrome
1 trial -
Sufentanil
The First People's Hospital of Lianyungang
Arteriovenous Malformation
1 trial -
Tamsulosin Oral Capsule
The First People's Hospital of Lianyungang
Ischaemic Heart Disease (IHD)
1 trial -
Tenofovir Alafenamide 25 MG
The First People's Hospital of Lianyungang
Chronic Hepatitis C
1 trial -
Tenofovir Alafenamide Tablets
The First People's Hospital of Lianyungang
Chronic Hepatitis b
1 trial -
Thalidomide
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
Tirzepatide
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus
1 trial -
Tislelizumab
The First People's Hospital of Lianyungang
Advanced NSCLC
1 trial -
Tislelizumab + cisplatin + paclitaxel
The First People's Hospital of Lianyungang
Esophageal Squamous Cell Carcinoma
1 trial -
Tocilizumab
The First People's Hospital of Lianyungang
Multiple Myeloma
1 trial -
Tranexamic Acid
The First People's Hospital of Lianyungang
Postpartum Hemorrhage， Cesarean Section
1 trial -
Trastuzumab Rezetecan
The First People's Hospital of Lianyungang
Breast Cancer
1 trial
Frequently asked questions
How many clinical projects does First People's Hospital have?
186 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.